The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-chloro-N-(6-methyl-2-(thiophen-2-yl)imidazo[1,2-a]pyridin-3-yl)benzamide ID: ALA5081682
Cas Number: 372970-71-3
PubChem CID: 979726
Max Phase: Preclinical
Molecular Formula: C19H14ClN3OS
Molecular Weight: 367.86
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1ccc2nc(-c3cccs3)c(NC(=O)c3ccc(Cl)cc3)n2c1
Standard InChI: InChI=1S/C19H14ClN3OS/c1-12-4-9-16-21-17(15-3-2-10-25-15)18(23(16)11-12)22-19(24)13-5-7-14(20)8-6-13/h2-11H,1H3,(H,22,24)
Standard InChI Key: GVTBBTIQMDBGNJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
8.1637 -2.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1637 -3.1738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8689 -3.5783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8689 -1.9439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5742 -2.3566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5742 -3.1703 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3480 -3.4218 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8264 -2.7635 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3481 -2.1053 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6416 -2.7640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1219 -3.4251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8991 -3.1726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8991 -2.3554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1219 -2.1030 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.6005 -4.1991 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0536 -4.8063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3061 -5.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2543 -4.6363 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.7585 -6.1868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0104 -6.9634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8105 -7.1340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3582 -6.5219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1034 -5.7476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0640 -7.9109 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
7.4565 -3.5835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 4 2 0
2 3 2 0
3 6 1 0
5 4 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 2 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
8 10 1 0
7 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 17 1 0
21 24 1 0
2 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.86Molecular Weight (Monoisotopic): 367.0546AlogP: 5.28#Rotatable Bonds: 3Polar Surface Area: 46.40Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.56CX LogP: 4.87CX LogD: 4.87Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.54Np Likeness Score: -2.46
References 1. Rostrup F, Falk-Petersen CB, Harpso E K, Buchleithner S, Conforti I, Jung S, Gloriam DE, Schirmeister T, Wellendorph P, Fro Lund B.. (2021) Structural Determinants for the Mode of Action of Imidazopyridine DS2 at δ-Containing γ-Aminobutyric Acid Type A Receptors., 64 (8.0): [PMID:33847501 ] [10.1021/acs.jmedchem.0c02163 ]